Blood filtering device shows promise for stroke recovery in new trial
NCT ID NCT05128513
First seen Apr 29, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study tests a blood filtering device called DELP in people with acute hemorrhagic stroke. The device is already approved for another type of stroke and may help reduce brain damage by filtering harmful substances from the blood. The trial aims to see if DELP improves recovery and reduces disability in 356 adults aged 18-80 with specific types of brain bleeds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, 110016, China
Conditions
Explore the condition pages connected to this study.